{"database": "openregs", "table": "documents", "rows": [["FDA-2020-E-2335-0005", "FDA", "FDA-2020-E-2335", "Determination of Regulatory Review Period for Purposes of Patent Extension; ROZLYTREK TABLETS, New Drug Application 212725", "Notice", "Determinations", "2022-08-02T04:00:00Z", 2022, 8, "2024-01-25T05:00:00Z", "2022-10-04T03:59:59Z", "2024-01-25T14:32:47Z", "2022-16504", 0, 0, "0900006485204eff"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2020-E-2335-0005"], "units": {}, "query_ms": 0.3553649876266718, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}